Intrinsic toxicity of glucose, due to non-enzymatic glycation, is controlled in-vivo by deglycation systems including: FN3K-mediated deglycation of fructosamines and transglycation of aldosamines

Medical Hypotheses

Volumn 65, Issue 2, 2005, Pages 337-348

  Szwergold, Benjamin S ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSAMINE; AMINE; AMINO ACID; ANSERINE; CARNOSINE; FRUCTOSAMINE; FRUCTOSAMINE 3 KINASE; GLUCOSE; GLUTATHIONE; LYSINE; MULTIDRUG RESISTANCE PROTEIN; PEPTIDE; PHOSPHOTRANSFERASE; SCHIFF BASE; UNCLASSIFIED DRUG;

ARTICLE; CELL DEATH; CELL GROWTH; DIABETES MELLITUS; DNA SYNTHESIS; DRUG DESIGN; EXTRACELLULAR SPACE; GLYCATION; HUMAN; HYPERGLYCEMIA; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REGULATORY MECHANISM;

AMINES; ANIMALS; ANSERINE; DIABETES MELLITUS; DRUG RESISTANCE; DRUG RESISTANCE, MULTIPLE; FRUCTOSAMINE; GLUCOSE; GLYCOSYLATION; HEMOGLOBINS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MAILLARD REACTION; MODELS, CHEMICAL; MODELS, THEORETICAL; OXYGEN; PHOSPHATES; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); TEMPERATURE;

ANIMALIA; HEXAPODA;

EID: 19744362561     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.02.017     Document Type: Article

References (52)

1. S. Naess Diabetes mellitus and comorbidity. Change between 1984-1986 and 1995-1997: results of the Nord-Trondelag Health Study J Diab Comp 17 2003 323 330
2. J.S. Skyler, and C. Oddo Diabetes trends in the USA Diab/Met Res Rev 18 Suppl 3 2002 S21 S26
3. Anonymous. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med 2000;342:381-9
4. R.C. Turner, C.A. Cull, V. Frighi, and R.R. Holman Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group JAMA 281 1999 2005 2012
5. M.J. Sheetz, and G.L. King Molecular understanding of hyperglycemia's adverse effects for diabetic complications JAMA 288 2002 2579 2588
6. A.W. Stitt, A.J. Jenkins, and M.E. Cooper Advanced glycation end products and diabetic complications Exp Opinion Invest Drugs 11 2002 1205 1223
7. P.E. Morgan, R.T. Dean, and M.J. Davies Inactivation of cellular enzymes by carbonyls and protein-bound glycation/glycoxidation products Arch Biochem Biophys 403 2002 259 269
8. F.N. Ziyadeh, and M.P. Cohen Effects of glycated albumin on mesangial cells: evidence for a role in diabetic nephropathy Mol Cell Biochem 125 1993 19 25
9. T. Wendt Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy J Am Soc Nephr 14 2003 1383 1395
10. R.A. Cohen Determinants of retinopathy progression in type 1 diabetes mellitus Am J Med 107 1999 45 51
11. D.A. Tinker, J.T. Brosnan, and G.R. Herzberg Interorgan metabolism of amino acids, glucose, lactate, glycerol and uric acid in the domestic fowl (Gallus domesticus) Biochem J 240 1986 829 836
12. R. Rosa, E. Rodrigues, and M. Bacila Blood glucose partition and levels of glycoytic enzymes in erythrocytes and somatic tissues of penguins Comp Biochem Physiol B 92 1989 307 311
13. M. Ferrer, T. Garcia-Rodriguez, J.C. Carrillo, and J. Castroviejo Hematocrit and blood chemistry values in captive raptors (Gyps fulvus, Buteo buteo, Milvus migrans, Aquila heliaca) Comp Biochem Physiol A-Comp Physiol 87 1987 1123 1127
14. C.A. Beuchat, and C.R. Chong Hyperglycemia in hummingbirds and its consequences for hemoglobin glycation Comp Biochem Physiol Part A Mol Integ Physiol 120 1998 409 416
15. I.Z. Nagy On the true role of oxygen free radicals in the living state, aging, and degenerative disorders Ann NY Acad Sci 928 2001 187 199
16. O.R. Koch Oxidative stress and antioxidant defenses in ethanol-induced cell injury Mol Aspects Med 25 2004 191 198
17. R.M. Bikowski, and C.K. Smith Glycemic control: arguments for and against Primary Care; Clin Office Practice 15 1988 311 326
18. Anonymous. Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Diabetes. 1999;48:383-90
19. Anonymous. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diab Care 1999;22:99-111
20. A.I. Adler UKPDS GROUP. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64) Kidney Int 63 2003 225 232
21. I.M. Stratton Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 321 2000 405 412
22. D.J. Holmes, R. Fluckiger, and S.N. Austad Comparative biology of aging in birds: an update Exp Gerontol 36 2001 869 883
23. L.I. Crawshaw Temperature regulation in vertebrates Ann Rev Physiol 42 1980 473 491
24. B.S. Szwergold Identification of a novel protein kinase activity specific for Amadori adducts on glycated proteins Diabetes 46 1997 108A
25. S. Kikuchi Neurotoxicity of methylglyoxal and 3-deoxyglucosone on cultured cortical neurons: synergism between glycation and oxidative stress, possibly involved in neurodegenerative diseases J Neurosci Res 57 1999 280 289
26. U.J. Eriksson, P. Wentzel, H.S. Minhas, and P.J. Thornalley Teratogenicity of 3-deoxyglucosone and diabetic embryopathy Diabetes 47 1998 1960 1966
27. H. Kato, N. van Chuyen, T. Shinoda, F. Sekiya, and F. Hayase Metabolism of 3-deoxyglucosone, an intermediate compound in the Maillard reaction, administered orally or intravenously to rats Biochem Biophys Acta 1035 1990 71 76
28. M. Oimoni Purification of α-ketoaldehyde dehydrogenase from the human liver and its possible significance in the control of glycation Experientia 45 1989 463 466
29. J.M. McCord Superoxide dismutase in aging and disease: an overview Meth Enzymol 349 2002 331 341
30. H. Aebi Catalase in vitro Meth Enzymol 105 1984 121 126
31. G. Delpierre Identification, cloning and heterologous expression of a mammalian fructosamine-3-kinase Diabetes 49 2000 1627 1634
32. B.S. Szwergold, S.K. Howell, and P.J. Beisswenger Human fructosamine-3-kinase [FN3K]: purification, sequencing, substrate specificity and evidence of activity in-vivo Diabetes 50 2001 2139 2147
33. G. Delpierre, F. Collard, J. Fortpied, and E. Van Schaftingen Fructosamine-3-kinase is involved in an intracellular deglycation pathway in human erythrocytes Biochem J 365 2002 801 808
34. G. Delpierrre Identification of fructosamine residues deglycated by fructosamine-3-kinase in human hemoglobin J Biol Chem 279 2004 27613 27620
35. C.L. Rohlfing Defining the relationship between plasma glucose and HbA[1c]: analysis of glucose profiles and HbA[1c] in the Diabetes Control and Complications Trial Diab Care 25 2002 275 278
36. H.B. Mortensen, and M.O. Marshall Effects of saline incubation on red cell content of glucosylated hemoglobins studied by iso-electric focusing Clin Chim Acta 132 1983 213 217
37. C.M. Breitling-Utzmann, A. Unger, D.A. Friedl, and M.O. Lederer Identification and quantification of phosphatidylethanolamine-derived glucosylamines and aminoketoses from human erythrocytes - influence of glycation products on lipid peroxidation Arch Biochem Biophys 391 2001 245 254
38. Conner JR, Beisswenger PJ, Szwergold BS. The expression of the genes for fructosamine-3-kinase and fructosamine-3-kinase-related protein in man and other organisms, Ann NY Acad Sci, in-press
39. G. Rappa, A. Lorico, R.A. Flavell, and A. Sartorelli Evidence that the Multidrug resistance Protein [MRP] Functions as a Co-transporter of Glutathione and Natural product Toxins Cancer Res 57 1997 5232 5237
40. A. Meister, and M.E. Anderson Glutathione Ann Rev Biochem 52 1983 711 760
41. J.R. Carey Demographic mechanisms for the evolution of long life in social insects Exp Geront 36 2002 713 722
42. B.J. Borrell, and M.J. Medeiros Thermal stability and muscle efficiency in hovering orchid bees J Exp Biol 207 2004 2925 2933
43. S.P. Roberts, J.F. Harrison, and N.F. Hadley Mechanisms of thermal balance in flying Centris pallida [Hymenoptera: Anthophoridae] J Exp Biol 201 1998 2321 2331
44. G.R. Wyatt The biochemistry of the insect hemolymph Ann Rev Ent 6 1961 75 102
45. D. Gilmour The biochemistry of insects 1961 Academic Press New York 235 237
46. A. Becker, P. Schloder, J.E. Steele, and G. Wegener The regulation of trehalose metabolism in insects Experientia 52 1996 433 439
47. Beutler E. Composition of the Erythrocyte, in Williams Hematology, 2001, pp. 289-93
48. B. Ramamurthy, A.D. Jones, and L. Larsson Glutathione reverses early effects of glycation on myosin function Am J Physiol 285 2003 C419 C424
49. Q.D. Wu Taurine prevents high-glucose-induced human vascular endothelial cell apoptosis Am J Physiol 277 1999 C1229 C1238
50. A.R. Hipkiss Pluripotent protective effects of carnosine, a naturally ocurring dipeptide Ann NY Acad Sci 854 1998 37 53
51. Y. Keita Influence of penicillamine on the formation of early non-enzymatic glycation products of human serum proteins Int J Clin Pharnacol Therapy Toxicol 30 1992 441 442
52. P. Odetti Comparative trial of N-acetyl-cysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes Diabetes 52 2003 499 505